強気
$162.17
シナリオ価格
$177.000
+3.859 (+2.18%)終値時点
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Balchem Corp is a good buy right now due to its strong financial performance and positive market sentiment. The current price is $177, and the company has shown a significant year-to-date change of +14.92%. Additionally, the forward P/E ratio is 29.33, indicating reasonable valuation compared to its growth prospects. The main risk is the high RSI of 86.18, suggesting that the stock may be overbought in the short term, but the overall fundamentals support a long-term investment.
シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。
Balchem Reports Record Q3 Earnings Driven by Specialty Ingredients

Balchem Corporation Q2 2026 Earnings Call Highlights

Balchem Reports Strong Q2 2026 Financial Results with Record Sales and Earnings

Balchem Q2 Earnings Exceed Expectations

Balchem Corporation to Participate in CJS Securities Conference
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia. It operates in the Basic Materials sector (CHEMICALS & ALLIED PRODUCTS industry).
Balchem Corp is a good buy right now due to its strong financial performance and positive market sentiment. The current price is $177, and the company has shown a significant year-to-date change of +14.92%. Additionally, the forward P/E ratio is 29.33, indicating reasonable valuation compared to its growth prospects. The main risk is the high RSI of 86.18, suggesting that the stock may be overbought in the short term, but the overall fundamentals support a long-term investment.
投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。